From January 1, 2024 to March 31, 2024, the company has repurchased 10,000 shares, representing 0.03% for $0.22 million. With this, the company has completed the repurchase of 2,773,000 shares, representing 9.24% for $99.6 million under the buyback announced on March 8, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.98 USD | +3.41% |
|
+9.70% | -24.07% |
07-01 | Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell 2000 Value-Defensive Index | CI |
07-01 | Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell 2000 Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.07% | 636M | |
-18.17% | 8.55B | |
+86.24% | 4.63B | |
+16.31% | 2.98B | |
-3.15% | 2.65B | |
-3.37% | 1.89B | |
-53.27% | 1.81B | |
-12.97% | 1.56B | |
+21.59% | 1.27B | |
-47.96% | 1.07B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.